文献速递新发突发、热带与寄生虫病

疫苗诱导的CSP C端表位抗体与疟疾攻击保护相关

Vaccine-Induced Antibodies to a C-Terminal Plasmodium falciparum Circumsporozoite Protein Epitope Associated With Protection Against Malaria Challenge.
PubMed 文献 · J Infect Dis · 2026-01-01

研究利用受控人类疟疾感染试验血清,采用覆盖CSP遗传变异的肽阵列,比较全长重组CSP疫苗未保护者、RTS,S未保护者与RTS,S保护者的抗CSP抗体反应广度与强度,发现保护者对接头区、中央重复区和C端区肽段反应广度更高,且对两个C端肽段(含Th3R部分)反应强度更高。

要点

  • RTS,S保护者对接头区、中央重复区和C端区肽段抗体反应广度高于未保护者。
  • RTS,S保护者对含Th3R部分的两个C端肽段抗体反应强度更高。
  • 保护者对C端表位PNDPNRNV变异及接头区相似序列的IgA反应广度更高。

核心结论

  • 针对RTS,S未包含的接头区表位的保护相关抗体反应提示疫苗诱导的交叉反应可提供额外获益。

研究设计与样本

  • 利用评估疫苗效力的受控人类疟疾感染试验血清,以覆盖CSP遗传变异的肽阵列定量抗CSP抗体反应。
  • 比较全长重组CSP疫苗未保护成人、RTS,S保护成人与RTS,S未保护成人的反应广度与强度。

主要发现

  • 总体而言,rCSP受者CSP抗体反应低于RTS,S保护组。
  • 与未保护组相比,RTS,S保护者对接头区、中央重复区和C端区肽段的反应广度更高。
  • RTS,S保护者对两个C端肽段(包括Th3R的一部分)的反应强度更高。
  • RTS,S保护者对C端表位PNDPNRNV变异及接头区相似序列的IgA反应广度更高,该表位经基序识别软件鉴定为优势基序。

临床怎么用

  • 下一代疟疾疫苗设计可关注诱导针对接头区表位的交叉反应抗体,以补充针对疫苗包含肽段的抗体反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Plasmodium falciparum circumsporozoite protein (CSP) is the target of multiple malaria vaccines that include only a part of the protein, such as RTS,S and R21. The monoclonal antibodies L9 and CIS43 are directed against key CSP junctional region epitopes not included in RTS,S and R21, and next-generation vaccine candidates attempt to elicit similar antibodies. Understanding the effectiveness of multiple antibody responses against CSP peptides will inform next-generation vaccines. METHODS: Using serum samples collected during controlled human malaria infection experiments that evaluated vaccine efficacy, we used a peptide array inclusive of CSP genetic variants to quantify anti-CSP antibody responses in unprotected adults who received a full-length recombinant CSP vaccine (rCSP), protected adults who received RTS,S, and unprotected adults who received RTS,S. We compared the breadth and intensity of responses to CSP variants between groups. RESULTS: Overall, rCSP recipients had lower CSP antibody responses compared with the protected RTS,S group. Compared with the unprotected groups, protected RTS,S vaccinees had higher breadth of responses to peptides in the junctional region, central repeat region, and C-terminal region. The protected RTS,S group also had higher intensity of responses to 2 C-terminal peptides, including part of Th3R. In addition, protected RTS,S recipients had higher breadth of immunoglobulin A responses to variants of the C-terminal epitope PNDPNRNV, identified as a dominant motif by motif recognition software, and to similar sequences in the junctional region. CONCLUSIONS: Protection-associated antibody responses to the junctional region not contained in RTS,S suggest a cross-reactive, vaccine-induced response that provides additional benefit beyond antibodies targeting vaccine peptides.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Friedman-Klabanoff DJ, Jensen TL, Gelber CE, et al. Vaccine-Induced Antibodies to a C-Terminal Plasmodium falciparum Circumsporozoite Protein Epitope Associated With Protection Against Malaria Challenge. J Infect Dis. 2026. PMID: 40826493. doi:10.1093/infdis/jiaf391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。